214 related articles for article (PubMed ID: 21470489)
1. Distinct proteinase 3-induced cytokine patterns in Wegener´s granulomatosis, Churg-Strauss syndrome, and healthy controls.
Fagin U; Csernok E; Müller A; Pitann S; Fazio J; Krause K; Bremer P; Wipfler-Freissmuth E; Moosig F; Gross WL; Lamprecht P
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S57-62. PubMed ID: 21470489
[TBL] [Abstract][Full Text] [Related]
2. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; Limburg PC; Kallenberg CG
Arthritis Rheum; 2008 Jul; 58(7):2196-205. PubMed ID: 18576340
[TBL] [Abstract][Full Text] [Related]
3. Membrane proteinase 3 (mPR3) expression on neutrophils is not increased in localized Wegener's granulomatosis (WG) and Churg-Strauss syndrome (CSS).
Holle JU; Wu QJ; Moosig F; Gross WL; Csernok E
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):46-50. PubMed ID: 20412702
[TBL] [Abstract][Full Text] [Related]
4. Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis.
Rani L; Minz RW; Sharma A; Anand S; Gupta D; Panda NK; Sakhuja VK
Cytokine; 2015 Feb; 71(2):261-7. PubMed ID: 25461407
[TBL] [Abstract][Full Text] [Related]
5. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
[TBL] [Abstract][Full Text] [Related]
6. Frequency of proteinase 3 (PR3)-specific autoreactive T cells determined by cytokine flow cytometry in Wegener's granulomatosis.
Winek J; Mueller A; Csernok E; Gross WL; Lamprecht P
J Autoimmun; 2004 Feb; 22(1):79-85. PubMed ID: 14709416
[TBL] [Abstract][Full Text] [Related]
7. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.
Jakiela B; Sanak M; Szczeklik W; Sokolowska B; Plutecka H; Mastalerz L; Musial J; Szczeklik A
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S23-34. PubMed ID: 21470488
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Csernok E; Szymkowiak CH; Mistry N; Daha MR; Gross WL; Kekow J
Clin Exp Immunol; 1996 Jul; 105(1):104-11. PubMed ID: 8697616
[TBL] [Abstract][Full Text] [Related]
10. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
[TBL] [Abstract][Full Text] [Related]
11. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
12. Current knowledge on cellular interactions in the WG-granuloma.
Lamprecht P; Gross WL
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S49-51. PubMed ID: 17428367
[TBL] [Abstract][Full Text] [Related]
13. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
14. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome.
Kiene M; Csernok E; Müller A; Metzler C; Trabandt A; Gross WL
Arthritis Rheum; 2001 Feb; 44(2):469-73. PubMed ID: 11229479
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.
Popa ER; Franssen CF; Limburg PC; Huitema MG; Kallenberg CG; Tervaert JW
Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
17. Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis.
Csernok E; Holle JU; Gross WL
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S112-7. PubMed ID: 18799068
[TBL] [Abstract][Full Text] [Related]
18. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.
Millet A; Martin KR; Bonnefoy F; Saas P; Mocek J; Alkan M; Terrier B; Kerstein A; Tamassia N; Satyanarayanan SK; Ariel A; Ribeil JA; Guillevin L; Cassatella MA; Mueller A; Thieblemont N; Lamprecht P; Mouthon L; Perruche S; Witko-Sarsat V
J Clin Invest; 2015 Nov; 125(11):4107-21. PubMed ID: 26436651
[TBL] [Abstract][Full Text] [Related]
19. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1, and NOD2.
Uehara A; Hirabayashi Y; Takada H
Clin Vaccine Immunol; 2008 Jul; 15(7):1060-6. PubMed ID: 18495849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
